The future of Digital Therapeutics (DTx): Perspectives and market projections
Digital Therapeutics (DTx) are transforming healthcare. They offer an innovative approach with the potential to revolutionize treatments, while also enabling real-time monitoring. Healthcare systems are accelerating their implementation, with evidence already available about their benefits.
Merry Christmas and a Happy New Year from Persei vivarium!
The team at Persei vivarium wishes you a very Happy Holiday Season and a New Year filled with health, success, and great opportunities.
For us, 2024 has been a year of progress, focused on advancing our commitment to improving patient health outcomes through digital innovation.
Evolution of Digital Health: What has changed and what do we expect?
The COVID-19 pandemic created a “before” and an “after” in many areas, without a doubt including Digital Health. The pandemic conditions promoted telemedicine, like other digital tools, as the best answer to reducing physical contact and the burden on hospitals, while maintaining medical care.
“GESO a pie de cama”: Improving obstetric care and safety in Spain using Persei vivarium technology
Last week marked the launch of “GESO a pie de cama”, an initiative that complements all the projects of the Spanish Group for Obstetric Safety (GESO). This time, it enables obstetricians, through a mobile application, to efficiently collect up-to-date data on maternal and perinatal morbidity and mortality.
What are the benefits of fast-track approval for Digital Therapeutics (DTx)?
As we have seen, Digital Therapeutics (DTX) go one step beyond Digital Health tools, becoming clinically validated solutions that meet the technical requirements and certifications that are necessary for their use in preventing, managing, or treating conditions and/or diseases.
What can Digital Health do in Oncology?
For many years, cancer has been one of the largest and most significant categories of disease around the world. In 2020, 18.1 million new cases of cancer were diagnosed worldwide. In Spain alone, it is estimated that there could be 286,664 cases in 2024, according to data from REDECAN (the Spanish Cancer Registry Network).